CONCERT PHARMACEUTICALS INC. Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for CONCERT PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the CONCERT PHARMACEUTICALS INC. trademark a serial number of 88177727. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 14, 2022. This trademark is owned by Concert Pharmaceuticals, Inc.. The CONCERT PHARMACEUTICALS INC. trademark is filed in the Pharmaceutical Products category with the following description:

a full line of pharmaceuticals, none of the aforesaid including pharmaceuticals for the treatment of attention deficit hyperactivity disorders and/or attention deficit disorders
concert pharmaceuticals inc.

General Information

Serial Number88177727
Word MarkCONCERT PHARMACEUTICALS INC.
Filing DateThursday, November 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Description of MarkThe mark consists of the word "CONCERT" with the "O" in lower case form and the "N" larger than the other upper case characters with the words "PHARMACEUTICALS INC." appearing in title case below "CONCERT".
Goods and Servicesa full line of pharmaceuticals, none of the aforesaid including pharmaceuticals for the treatment of attention deficit hyperactivity disorders and/or attention deficit disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameConcert Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameConcert Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, November 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2022SOU EXTENSION 5 GRANTED
Thursday, April 7, 2022SOU EXTENSION 5 FILED
Thursday, April 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 7, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 6, 2021SOU EXTENSION 4 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 4 FILED
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 3 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 3 FILED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2020SOU EXTENSION 2 GRANTED
Wednesday, October 7, 2020SOU EXTENSION 2 FILED
Wednesday, October 7, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, April 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2020SOU EXTENSION 1 GRANTED
Monday, April 6, 2020SOU EXTENSION 1 FILED
Monday, April 6, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 6, 2019ASSIGNED TO LIE
Monday, July 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Friday, November 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 5, 2018NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals concert attention deficit disorders treatment hyperactivity including line none aforesaid